UBS Group’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

UBS Group’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,600	Closed	-$234	–	11003
2024 Q4	$234	Buy	+2,600	New	+$210	﹤0.01%	9556
2022 Q4	–	Sell	-4,812	Closed	-$2K	–	11263
2022 Q3	$2K	Buy	4,812 +195	+4%	+$86	﹤0.01%	9801
2022 Q2	$1K	Buy	4,617 +61	+1%	+$42	﹤0.01%	10013
2022 Q1	$4K	Buy	4,556 +1,088	+31%	+$967	﹤0.01%	9337
2021 Q4	$4K	Buy	+3,468	New	+$4.32K	﹤0.01%	9558

Other funds holding CTV.WS

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

UBS Group's CTV.WS Position: Q1 2025 in Review

UBS Group sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2025, closing a stake of 2,600 shares — an estimated $234 sold.

UBS Group first reported a position in CTV.WS in Q4 2021 and held it in 5 quarters. The position peaked at $4K in Q1 2022. 1 fund tracked by Wall St. Rank holds CTV.WS as of Q1 2025.

UBS Group reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2025 after selling out during the quarter.
UBS Group sold 2,600 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2025, an estimated $234.
UBS Group first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 5 quarters.
UBS Group's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $4K in Q1 2022.
1 fund tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.